Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Jinru Wei

Biographic Data

ID9802484
NAMEJinru Wei
GIVEN NAMESJinru
FAMILY NAMEWei
SIGNATUREWEI J
AFFILIATIONSProvidence College
ORCID0009-0007-4514-9967
VERIFIEDYes
TOTAL WORKS3
TOTAL CITATIONS0
WORKS AS AUTHOR3
WORKS AS EDITOR0
FIRST PUBLICATION YEAR2025
LATEST PUBLICATION YEAR2025
H-INDEX0
  • An assessment of antimicrobial resistance national action plans and their impact on antibiotic use

    Open Access•Emily O’Neill, Jinru Wei et al.•ARTICLE•BMJ Global Health•2025

    INTRODUCTION: By 2050, antimicrobial resistance (AMR) could lead to over 10 million deaths annually and $100 trillion in healthcare costs, making it one of the most urgent public health threats. The WHO recommends AMR National Action Plans (AMR NAPs) to address this threat, but the effectiveness of these plans is unknown. METHODS: We estimate the impact of AMR NAPs on retail sales of all antibiotics across 68 countries from 2014 to 2023 using IQV…

  • Prices and Affordability of Essential Medicines in 72 Low-, Middle-, and High-Income Markets

    Open Access•Olivier J Wouters, Cyprien Denolle et al.•ARTICLE•JAMA Health Forum•2025

    The results of this cross-sectional analysis showed significant variation in the prices and affordability of 549 essential medicines across 72 markets in 2022. Strategies to promote equitable drug prices and improve drug affordability are urgently needed

  • Racial Disparities in Premature Mortality and Unrealized Medicare Benefits Across US States

    Open Access•Irene Papanicolas, Maecey Niksch et al.•ARTICLE•JAMA Health Forum•2025

    This cohort study examines racial disparities in premature mortality in the US and discusses the implications of these trends for unrealized Medicare benefits among populations with lower life expectancies

No prominent works on this page.

  • An assessment of antimicrobial resistance national action plans and their impact on antibiotic use

    Open Access•Emily O’Neill, Jinru Wei et al.•ARTICLE•BMJ Global Health•2025

    INTRODUCTION: By 2050, antimicrobial resistance (AMR) could lead to over 10 million deaths annually and $100 trillion in healthcare costs, making it one of the most urgent public health threats. The WHO recommends AMR National Action Plans (AMR NAPs) to address this threat, but the effectiveness of these plans is unknown. METHODS: We estimate the impact of AMR NAPs on retail sales of all antibiotics across 68 countries from 2014 to 2023 using IQV…

  • Prices and Affordability of Essential Medicines in 72 Low-, Middle-, and High-Income Markets

    Open Access•Olivier J Wouters, Cyprien Denolle et al.•ARTICLE•JAMA Health Forum•2025

    The results of this cross-sectional analysis showed significant variation in the prices and affordability of 549 essential medicines across 72 markets in 2022. Strategies to promote equitable drug prices and improve drug affordability are urgently needed

  • Racial Disparities in Premature Mortality and Unrealized Medicare Benefits Across US States

    Open Access•Irene Papanicolas, Maecey Niksch et al.•ARTICLE•JAMA Health Forum•2025

    This cohort study examines racial disparities in premature mortality in the US and discusses the implications of these trends for unrealized Medicare benefits among populations with lower life expectancies

Population (2 works) · Antibiotic resistance (1 work) · Antibiotic Resistance in Bacteria (1 work) · Antibiotic Use and Resistance (1 work) · Antibiotics (1 work) · Antibiotics Pharmacokinetics and Efficacy (1 work) · Antimicrobial (1 work) · Azithromycin (1 work) · Biosimilars and Bioanalytical Methods (1 work) · Chronic Disease Management Strategies (1 work)

Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae